FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048589111> ?p ?o ?g. }

• W2048589111 endingPage "575" @default.
• W2048589111 startingPage "573" @default.
• W2048589111 abstract "International Journal of DermatologyVolume 33, Issue 8 p. 573-575 PSORIASIS TREATMENT WITH 5-AMINOSALICYLIC ACID ROBERTO CORTES-FRANCO M.D., Corresponding Author ROBERTO CORTES-FRANCO M.D. From the Department of Dermatology, Hospital General‘Dr. Manuel Gea Gonzalez’ Mexico D.F., Mexico.Address for correspondence: Roberto Cortés-Franco, M.D., Calz. de Tlalpan 4800, Col. Toriello Guerra, México, D.F., C.P. 14000, Mexico.Search for more papers by this authorLUISA M. FERNANDEZ M.D., LUISA M. FERNANDEZ M.D. From the Department of Dermatology, Hospital General‘Dr. Manuel Gea Gonzalez’ Mexico D.F., Mexico.Search for more papers by this authorLUCIANO DOMINGUEZ-SOTO M.D., LUCIANO DOMINGUEZ-SOTO M.D. From the Department of Dermatology, Hospital General‘Dr. Manuel Gea Gonzalez’ Mexico D.F., Mexico.Search for more papers by this author ROBERTO CORTES-FRANCO M.D., Corresponding Author ROBERTO CORTES-FRANCO M.D. From the Department of Dermatology, Hospital General‘Dr. Manuel Gea Gonzalez’ Mexico D.F., Mexico.Address for correspondence: Roberto Cortés-Franco, M.D., Calz. de Tlalpan 4800, Col. Toriello Guerra, México, D.F., C.P. 14000, Mexico.Search for more papers by this authorLUISA M. FERNANDEZ M.D., LUISA M. FERNANDEZ M.D. From the Department of Dermatology, Hospital General‘Dr. Manuel Gea Gonzalez’ Mexico D.F., Mexico.Search for more papers by this authorLUCIANO DOMINGUEZ-SOTO M.D., LUCIANO DOMINGUEZ-SOTO M.D. From the Department of Dermatology, Hospital General‘Dr. Manuel Gea Gonzalez’ Mexico D.F., Mexico.Search for more papers by this author First published: August 1994 https://doi.org/10.1111/j.1365-4362.1994.tb02900.xCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Brain, S, Camp, R, Dowd, P, et al. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol 1984; 83: 70–73. 2 Duell, EA, Ellis, C, Voorhees, JJ. Determination of 5, 12, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin. J Invest Dermatol 1988; 91: 446–450. 3 Barr, R, Wong, E, Mallet, A, et al. The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin. Prostaglandins 1984; 28: 57–65. 4 Brain, S, Camp, R, Black, A, et al. Leukotrienes C4 and D4 in psoriatic skin lesions. Prostaglandins 1985; 29: 611–619. 5 Ruzicka, T, Simmer, T, Peskar, B, Ring, J. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 1986; 86: 105–108. 6 Gupta, AK, Ellis, CN, Siegel, MT, Voorhees, JJ. Sulfasalazine: a potential psoriasis therapy J Am Acad Dermatol 1989; 20: 797–800. 7 Fernández, L, Cortés-Franco, R, Dominguez-Soto, L. Psoriasis: tratamiento de 20 casos con sulfasalazina. Dermatologia Rev Mex 1993; 37: 301–304. 8 Gupta, AK, Ellis, CN, Siegel, MT, et al. Sulfasalazine improves psoriasis. A double blind analysis. Arch Dermatol 1990; 126: 487–493. 9 Azad, K, Piris, J, Truelove, SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977; ii: 892–895. 10 Van Hees, PAM, Bakker, JH, Van Tongeren, JHM. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis. A study to determine the active therapeutic moiety of sulphasalazine. Gut 1980; 21: 632–635. 11 Taffet, SL, Das, KM. Sulfasalazine. Adverse effects and desensitization. Dig Dis Sci 1983; 28: 833–842. 12 Sutherland, LR, May, GR, Shaffer, EA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 540–549. 13 Sanders, C, Hulsmans, R. Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid. Cutis 1993; 50: 262–264. 14 Stenson, WF, Lobos, E. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest 1982; 69: 494–497. Citing Literature Volume33, Issue8August 1994Pages 573-575 ReferencesRelatedInformation" @default.
• W2048589111 created "2016-06-24" @default.
• W2048589111 creator A5014177910 @default.
• W2048589111 creator A5034619284 @default.
• W2048589111 creator A5068391074 @default.
• W2048589111 date "1994-08-01" @default.
• W2048589111 modified "2023-10-18" @default.
• W2048589111 title "PSORIASIS TREATMENT WITH 5-AMINOSALICYLIC ACID" @default.
• W2048589111 cites W1995574368 @default.
• W2048589111 cites W1995733311 @default.
• W2048589111 cites W1999197985 @default.
• W2048589111 cites W2027813069 @default.
• W2048589111 cites W2043530745 @default.
• W2048589111 cites W2053766239 @default.
• W2048589111 cites W2056817635 @default.
• W2048589111 cites W2063028339 @default.
• W2048589111 cites W2073102792 @default.
• W2048589111 cites W2162798660 @default.
• W2048589111 cites W4249993968 @default.
• W2048589111 doi "https://doi.org/10.1111/j.1365-4362.1994.tb02900.x" @default.
• W2048589111 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7960356" @default.
• W2048589111 hasPublicationYear "1994" @default.
• W2048589111 type Work @default.
• W2048589111 sameAs 2048589111 @default.
• W2048589111 citedByCount "2" @default.
• W2048589111 countsByYear W20485891112014 @default.
• W2048589111 countsByYear W20485891112017 @default.
• W2048589111 crossrefType "journal-article" @default.
• W2048589111 hasAuthorship W2048589111A5014177910 @default.
• W2048589111 hasAuthorship W2048589111A5034619284 @default.
• W2048589111 hasAuthorship W2048589111A5068391074 @default.
• W2048589111 hasConcept C142362112 @default.
• W2048589111 hasConcept C15708023 @default.
• W2048589111 hasConcept C2992019943 @default.
• W2048589111 hasConcept C3019520520 @default.
• W2048589111 hasConcept C512399662 @default.
• W2048589111 hasConcept C71924100 @default.
• W2048589111 hasConceptScore W2048589111C142362112 @default.
• W2048589111 hasConceptScore W2048589111C15708023 @default.
• W2048589111 hasConceptScore W2048589111C2992019943 @default.
• W2048589111 hasConceptScore W2048589111C3019520520 @default.
• W2048589111 hasConceptScore W2048589111C512399662 @default.
• W2048589111 hasConceptScore W2048589111C71924100 @default.
• W2048589111 hasIssue "8" @default.
• W2048589111 hasLocation W20485891111 @default.
• W2048589111 hasLocation W20485891112 @default.
• W2048589111 hasOpenAccess W2048589111 @default.
• W2048589111 hasPrimaryLocation W20485891111 @default.
• W2048589111 hasRelatedWork W1990487014 @default.
• W2048589111 hasRelatedWork W2028289198 @default.
• W2048589111 hasRelatedWork W2073047514 @default.
• W2048589111 hasRelatedWork W2124909615 @default.
• W2048589111 hasRelatedWork W2417795968 @default.
• W2048589111 hasRelatedWork W2944897644 @default.
• W2048589111 hasRelatedWork W3156841781 @default.
• W2048589111 hasRelatedWork W3163450695 @default.
• W2048589111 hasRelatedWork W4210581901 @default.
• W2048589111 hasRelatedWork W4229777349 @default.
• W2048589111 hasVolume "33" @default.
• W2048589111 isParatext "false" @default.
• W2048589111 isRetracted "false" @default.
• W2048589111 magId "2048589111" @default.
• W2048589111 workType "article" @default.